In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum

Trop Med Int Health. 2003 Jan;8(1):25-9. doi: 10.1046/j.1365-3156.2003.00967.x.

Abstract

Objectives: To determine the in vitro activity of antimalarial drugs against isolates of Plasmodium falciparum in Gabon.

Methods: Plasmodium falciparum isolates were collected from symptomatic infections in the hospitals of Bakoumba and Franceville, south-east Gabon and in 2000. In vitro activity of chloroquine, quinine, mefloquine, halofantrine was measured by the isotopic microtest.

Results: A total of 60 and 62 isolates gave interpretable data in Franceville and Bakoumba, respectively. In Franceville, 50.0% (mean IC50 = 111.7 nm), 0% (mean IC50 = 156.7 nm), and 21.2% (mean IC50 = 12.4 nm) of isolates, respectively, showed in vitro resistance to chloroquine, quinine and mefloquine. In Bakoumba, we saw resistance to chloroquine, quinine, mefloquine and halofantrine in 95.0% (mean IC50 = 325.8 nm), 10.2% (mean IC50 = 385.5 nm), 47.5% (mean IC50 = 24.5 nm) and 18.2% (mean IC50 = 1.9 nm) of isolates, respectively. Activities of chloroquine and mefloquine, chloroquine and quinine, and mefloquine and quinine were positively correlated.

Conclusions: Antimalarial drug resistance is high in this area of Gabon. The extent of resistance is disparate, as all tested drugs were less efficacious in Bakoumba than in Franceville.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimalarials / therapeutic use*
  • Chloroquine / therapeutic use
  • Drug Resistance
  • Gabon
  • Humans
  • Inhibitory Concentration 50
  • Malaria, Falciparum / drug therapy*
  • Mefloquine / therapeutic use
  • Parasitic Sensitivity Tests / methods
  • Phenanthrenes / therapeutic use
  • Plasmodium falciparum / drug effects*
  • Quinine / therapeutic use

Substances

  • Antimalarials
  • Phenanthrenes
  • Chloroquine
  • Quinine
  • halofantrine
  • Mefloquine